Are clinical trials safe in India? Oversight, rights and red flags

Clinical trials in India are overseen at several levels, and no trial of a new medicine should begin without all of them. The national drug regulator, the Central Drugs Standard Control Organisation led by the Drugs Controller General of India, must approve trials of new medicines. Every trial must be reviewed and approved by a registered ethics committee, which includes members from outside medicine. The trial must be registered on the Clinical Trials Registry – India before the first participant joins. National ethical guidelines from the Indian Council of Medical Research set standards for consent and fairness. Together, these checks exist so that participants' rights, safety and wellbeing come before the interests of research.

The protections that exist are specific. You must receive information in a language you understand and give written informed consent, and for some trials the consent discussion is recorded on video. You can withdraw at any time without losing standard care. Serious side effects must be reported to the regulator and ethics committee within set timeframes. If you are injured because of the trial, the sponsor must provide free medical management, and compensation may be payable through a defined process. Ethics committees can monitor trials and suspend them. Your personal information must be kept confidential. In the past, public concern and court scrutiny over how some trials were run led to these rules being tightened.

Scepticism about trials is understandable, and some warning signs should make you stop. Be cautious if you are asked to pay for the trial medicine or a place in the study, pressured to sign quickly, offered payments that feel like an inducement, or not given a copy of the consent form. Be wary if nobody can name the ethics committee, the trial is not on CTRI, you are told to hide your participation from your own doctor, or you are promised that the treatment will help you. A genuine trial never promises benefit. Joining is voluntary, and a well-run trial welcomes questions, gives you time and respects your decision to say no.

Several layers of oversight

Regulator, ethics committee and public registration.

Protections are written into the rules

Consent, withdrawal and injury care are rights.

Promises are a red flag

No genuine trial promises benefit.

It cannot tell you whether a particular trial is well run or safe for you. Only the documents, the approvals and careful questions can help you judge that.

It also cannot tell you whether to join. Your treating oncologist can give you an independent view.

Why scepticism is reasonable

Stories of people enrolled without understanding, or of poor families being targeted, have shaped public trust in trials. Such concerns were not imagined, and they led to stronger rules. Asking hard questions is not rude or ungrateful. It is exactly what a careful participant, and a careful family, should do.

Safe does not mean without risk

Oversight makes trials safer, but it cannot remove the uncertainty of testing a new treatment. Side effects may be unexpected, and the treatment may not work. A well-regulated trial is one where risks are explained honestly, reduced where possible and monitored closely, not one where nothing can go wrong.

What ethics committees actually do

An ethics committee reads the full trial plan, the consent documents and any payments before approving a study. It includes doctors, scientists, legal experts and lay members. It receives reports of serious side effects during the trial and can ask for changes, pause enrolment or stop the study if participants are at unfair risk.

Contacting the ethics committee

The consent documents should give contact details for the ethics committee that approved the trial. You can contact it directly if you have concerns about how you are being treated, feel pressured, or believe your rights are not respected. You do not need the research team's permission to do this.

Checking registration on CTRI

Search the Clinical Trials Registry – India using the registration details on your documents. The entry should match what you were told about the purpose, sites and sponsor. If a trial cannot be found, or the details differ, ask the team to explain before you agree to anything.

Extra protection for vulnerable people

Indian guidelines give extra protection to people who may be more easily pressured, such as those who cannot read, people who are very ill, children and those in financial hardship. Protections may include an impartial witness, recorded consent and closer ethics review. These safeguards exist because vulnerability can make free choice harder.

Payments and inducement

Reimbursing reasonable expenses is acceptable. Offering money large enough to persuade someone to accept risks they otherwise would not is not. Ethics committees review payments for this reason. If the amount on offer seems to be the main reason to join, pause and discuss it with your oncologist and family.

Serious side effects

If something serious happens during a trial, the investigator must report it to the sponsor, the ethics committee and the regulator, and the cause is then assessed. You should receive medical care promptly. Keep your trial contact card with you, and tell any doctor you see that you are taking part.

Injury and compensation

Indian rules require the sponsor to pay for medical management of injury related to a trial, for as long as needed, and compensation may be awarded where the injury is linked to the trial. The consent form should explain this. Keep all records and report problems to the trial team without delay.

Your own oncologist's role

Your treating oncologist is not part of the trial team and can offer an independent view. They can review the documents, explain whether the study seems well designed and relevant, and help you judge the warning signs. Involving them is one of the simplest protections available to you.

International standards

Trials in India are expected to follow Good Clinical Practice, an international standard for designing, running and reporting research with people. Sponsors and hospitals may also be inspected by regulators. These standards aim to make results reliable and participants protected, wherever in the world a study is run.

When to walk away

If answers are vague, documents are missing, or you feel uneasy for reasons you cannot fully explain, it is reasonable to say no. Declining a trial does not affect your standard care. A trustworthy research team will respect your decision without argument and without making you feel guilty.

What to do next

Ask which ethics committee approved the trial, check its CTRI registration, read the consent documents with family, show them to your treating oncologist, and walk away if you notice any warning sign.